Insulet Corp. appointed Michael Minogue and James Mullen to its board of directors.

The company also said that Regina Sommer and Joseph Zakrzewski retired from the board.

Minogue is CEO, president and chairman of medical device manufacturer ABIOMED Inc.

Mullen is CEO of pharmaceutical contract development and manufacturing organization Patheon N.V., which is in the process of being acquired by Thermo Fisher Scientific Inc.